A 2nd story in NYTimes: Renewable Energy Stumbles Toward the Future

Link: http://www.nytimes.com/2016/04/24/business/energy-environment/renewable-energy-stumbles-toward-the-future.html?smid=nytcore-iphone-share&smprod=nytcore-iphone

——————–

In another story on what the SunEdison bankruptcy means for renewable energy (and doesn’t mean):

”This is going to be a big industry globally, but we’re stumbling and bumbling to get there,” said Erik Gordon, a clinical assistant professor at the Ross School of Business at the University of Michigan. “If they weren’t trying to beat each other to the next rooftop they wouldn’t be needing to do this financial engineering.”

The problems at companies like SunEdison resemble those of past leading-edge industries.

Erik Gordon
Ross School of Business
University of Michigan

Erik Gordon
Ross School of Business
University of Michigan

an AP story on the SEC consideration of reducing public company reporting to twice a year

Link: http://abcnews.go.com/Business/wireStory/earnings-sec-reduce-company-reports-38605284

——————–

at abc News:
http://abcnews.go.com/Business/wireStory/earnings-sec-reduce-company-reports-38605284

at CNBC:
http://www.cnbc.com/2016/04/22/the-associated-press-enough-with-the-earnings-sec-may-reduce-company-reports.html

Yahoo! Finance:
http://finance.yahoo.com/news/enough-earnings-sec-may-reduce-company-reports-193139800–finance.html

US News & World Report:
http://www.usnews.com/news/business/articles/2016-04-22/enough-with-the-earnings-sec-may-reduce-company-reports

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

PE funds get their way with investors, in Bloomberg BusinessWeek and The Washington Post

Link: http://www.bloomberg.com/news/articles/2016-04-13/top-performing-buyout-firms-get-what-they-from-eager-investors

——————–

A story about how the top PE firms are getting more advantageous deal terms
with investors who are scrambling for yield.

http://www.bloomberg.com/news/articles/2016-04-13/top-performing-buyout-firms-get-what-they-from-eager-investors

http://washpost.bloomberg.com/Story?docId=1376-O54ROA6JIJUR01-6S1H2R073ODSN3KQLFCUG0772V
_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

in Bloomberg BusinessWeek and The Washington Post, on the VW bonuses controversy

Link: http://www.bloomberg.com/news/articles/2016-04-11/volkswagen-s-management-bonuses-targeted-in-scandal-fallout

——————–

http://www.bloomberg.com/news/articles/2016-04-11/volkswagen-s-management-bonuses-targeted-in-scandal-fallout

http://washpost.bloomberg.com/Story?docId=1376-O5GN5V6KLVR901-2VQF44MFHJ420GUTHQIMIPVN4K
_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Tesla story on front page of the Sunday Detroit Free Press

Link: http://www.freep.com/story/money/cars/2016/04/09/tesla-electric-model-3/82659852/

——————–

A couple of quotations on the big challenges facing Tesla. One regards its
business model. One regards its relationship with investors. The story is
also at USA Today (Money section). The Free Press and USA Today are owned
by Gannett.

http://www.freep.com/story/money/cars/2016/04/09/tesla-electric-model-3/82659852/

http://www.usatoday.com/story/money/cars/2016/04/10/tesla-faces-five-big-challenges/82859740/

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

JNJ baby powder problems, in next week’s BusinessWeek print edition

Link: http://www.bloomberg.com/features/2016-baby-powder-cancer-lawsuits/

——————–

Next week’s BusinessWeek print edition has a feature story about JNJ’s
product liability problems with its baby powder. My mother used it on me.
It’s probably the reason I am bald.

http://www.bloomberg.com/features/2016-baby-powder-cancer-lawsuits/

_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

“All companies should know that transparency matters.”

Link: https://www.statnews.com/pharmalot/2016/03/29/valeant-lessons/

——————–

The Valeant example, in The Boston Globe and industry site: STAT.

“Transparency is the only way to build confidence

This is a basic tenet of corporate governance, but Valeant never learned
this lesson. The drug maker blundered badly by failing to report that it
held an option to buy a mail-order pharmacy that it was using to boost
revenues.

Instead, short sellers disclosed the relationship last fall, prompting
suspicion from insurance companies about the way reimbursements were
handled. Federal authorities are now examining the details.

The episode began the downward spiral in Valeant stock. A failure to follow
certain accounting practices further undermined investor confidence.

“The pharmaceutical industry is under such public scrutiny now that any
arrangement that’s kept secret is going to be presumed to be evil,” said
Erik Gordon, a business and law professor at the University of Michigan.
“All companies should know that transparency matters.” ”

What Valeant’s fall from grace can teach the drug industry


_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan